{"SPADE_UN_13528": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_13528", "Peptide Name": "IPB08(SARS-CoV-2-S (1169-1198)-K)", "Source": "Synthetic construct", "Family": "Belongs to the betacoronaviruses spike protein family.", "Gene": "S", "Sequence": "ISGINASVVNIQKEIDRLNEVAKNLNESLIK", "Sequence Length": 31, "UniProt Entry": ["http://www.uniprot.org/uniprot/P59594", "http://www.uniprot.org/uniprot/P0DTC2"], "Protein Existence": "Protein level", "Biological Activity": ["Antimicrobial", "Antiviral(SARS-CoV-2)"], "Target Organism": "[Ref.32376627]Virus:SARS-CoV-2:ihibition of cell-cell fusion in 293T/ACE2 cells(IC50=4.66 ± 1.565 µM),inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC50=1.738 ± 0.898 µM);SARS-CoV:inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC=1.13 ± 0.472 µM);Vesicular Stomatitis Virus (VSV):inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC50>50 µM).", "Hemolytic Activity": "No hemolysis information or data found in the reference(s) presented in this entry", "Cytotoxicity": "No cytotoxicity information found in the reference(s) presented", "Binding Target": "liposomes", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Chol", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C148H257N43O49", "Mass": 3422.88, "PI": 6.26, "Net Charge": 0, "Hydrophobicity": -0.13, "Half Life": "Mammalian:20 hourYeast:30 minE.coli:>10 hour", "Mechanism of action": "The peptide was designed based on HR2 sequence lipopeptide fusion inhibitor,which showed highly potent activities in inhibiting SARS-CoV-2 S protein-mediated cell-cell fusion and pseudovirus transduction. It can  also inhibit the SARS-CoV pseudovirus efficiently.", "Literature": [{"Title": "Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity.", "Pubmed ID": "32376627", "Reference": "J Virol. 2020 Jul 1;94(14)e00635-20.", "Author": "Zhu Y, Yu D, Yan H, Chong H, He Y.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=32376627"}], "Frequent Amino Acids": "INE", "Absent Amino Acids": "CFHMOPTUWY", "Basic Residues": 4, "Acidic Residues": 4, "Hydrophobic Residues": 13, "Polar Residues": 18, "Positive Residues": 4, "Negative Residues": 4, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_13853", "Similarity": 1.0, "Sequence": "GINASVVNIQKEIDRLNEVAKNL"}, {"SPADE_ID": "SPADE_UN_13529", "Similarity": 1.0, "Sequence": "SVVNIQKEIDRLNEVAKNLNESLIK"}, {"SPADE_ID": "SPADE_UN_13518", "Similarity": 0.967741935483871, "Sequence": "DISGINASVVNIQKEIDRLNEVAKNLNESLIDLQEL"}]}}}